What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Gene
His primary scientific interests are in Endocrinology, Internal medicine, Serotonin, Neuroscience and Schizophrenia.
Jack D. Barchas interconnects Dynorphin and Antiserum in the investigation of issues within Endocrinology.
His work in the fields of Serotonin, such as Serotonergic, overlaps with other areas such as Auditory startle.
His Neuroscience research is multidisciplinary, incorporating elements of Opioid and Severe Mental Disorders.
His Schizophrenia research is multidisciplinary, relying on both Major depressive disorder and Bipolar disorder.
His Bipolar disorder research includes themes of Genetics, Genetic heterogeneity, Genome-wide association study and Psychiatric genetics.
His most cited work include:
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (1570 citations)
- Amplified RNA synthesized from limited quantities of heterogeneous cDNA. (1232 citations)
- Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 (1131 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Endocrinology, Biochemistry, Serotonin and Dopamine.
In most of his Internal medicine studies, his work intersects topics such as Sleep in non-human animals.
His studies deal with areas such as Enzyme assay, Homovanillic acid and Opioid peptide as well as Endocrinology.
His study in Homovanillic acid is interdisciplinary in nature, drawing from both Metabolite and Cerebrospinal fluid.
His Biochemistry study deals with Molecular biology intersecting with Complementary DNA.
Serotonin is closely attributed to Pharmacology in his study.
He most often published in these fields:
- Internal medicine (44.89%)
- Endocrinology (44.66%)
- Biochemistry (14.25%)
What were the highlights of his more recent work (between 1989-2020)?
- Psychiatry (8.55%)
- Bipolar disorder (3.56%)
- Major depressive disorder (3.56%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Psychiatry, Bipolar disorder, Major depressive disorder, Genetics and Schizophrenia.
He combines subjects such as Psychotherapist, Mitochondrial DNA and Locus with his study of Psychiatry.
The concepts of his Bipolar disorder study are interwoven with issues in Disease and Psychiatric genetics.
His study with Major depressive disorder involves better knowledge in Endocrinology.
His Endocrinology research integrates issues from Microarray and Candidate gene.
His research in Schizophrenia intersects with topics in Genetic heterogeneity, Psychosis, Mood disorders and Age of onset.
Between 1989 and 2020, his most popular works were:
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (1570 citations)
- Amplified RNA synthesized from limited quantities of heterogeneous cDNA. (1232 citations)
- Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 (1131 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Gene
Jack D. Barchas spends much of his time researching Schizophrenia, Genome-wide association study, Bipolar disorder, Genetics and Major depressive disorder.
His Bipolar disorder study results in a more complete grasp of Psychiatry.
His Major depressive disorder study incorporates themes from Antidepressant, Lesion, Genetic heterogeneity and Human brain.
His Human brain research incorporates themes from ARNTL, Endocrinology, Cell aging and Internal medicine.
His Endocrinology study combines topics in areas such as Microarray, Sleep deprivation and Gene expression profiling.
His Internal medicine study frequently links to other fields, such as In situ hybridization.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
